Chimerix Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chimerix Inc with three other
companies in this sector in the United States:
sales of $5.56 million
Apricus Biosciences Inc
Sarepta Therapeutics Incorporated
of which 100%
was Grants & Research).
Chimerix Inc reported sales of $5.70 million
December of 2016.
decrease of 47.0%
versus 2015, when the company's sales were $10.76 million.